Pregnancy intention and opioid use disorder treatment retention in the MOTHER study

Am J Addict. 2018 Jul 11. doi: 10.1111/ajad.12735. Online ahead of print.

Abstract

Background and objectives: Opioid use disorder (OUD) during pregnancy challenges public health. This study examines how pregnancy intention affects OUD treatment.

Methods: The primary exposure and outcome were pregnancy intention and treatment duration among MOTHER (Maternal Opioid Treatment: Human Experimental Research) participants (N = 175).

Results: Treatment durations were longer (21.3 vs. 16.3 weeks; p = .01) among intended (n = 29) compared to unintended (n = 146) pregnancy participants, but this was not significant in adjusted analyses.

Discussion and conclusions: Unintended pregnancies intersect with OUD and may modify one's treatment outcomes.

Scientific significance: OUD treatment may be a setting to help women implement informed family planning choices. (Am J Addict 2018;XX:1-3).